Europe
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
A number of new medications stand a shot at early regulatory approval thanks to the U.S. Food and Drug Administration’s priority review program.
Bayer is moving closer to a $10 billion settlement over the Roundup lawsuits and the company is in the midst of restructuring.
New research indicates that a single dose of the human papillomavirus vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer.
BD, a leading global medical technology company, announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector.
Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications.
As the outbreak of the new coronavirus continues to spread, VIB scientists are quickly mobilizing to try to find a potential treatment for the viral infection.
Vectura Group plc announces a key appointment to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space.
Panthera, the newly launched independent clinical trial site management organisation, has opened its first site in Preston in the UK with a second site in North Manchester to open in March.
TreeFrog Therapeutics, a pure player in iPSC-derived cell therapies, announces the appointment of 2 senior executives and 2 independent board members.
PRESS RELEASES